VelaLabs – Meaningful Analytics

Analytical Characterization of Biomolecules

VelaLabs was founded in 2006 in the former Novartis Campus in Vienna. Since 2007, it is a GMP-certified service-oriented company with focus on analytical and quality control of biopharmaceutical products, as well as clinical development of biosimilars, biologics and ATMPs. By the acquisition of LABH in 2019, VelaLabs can now also offer all types of microbiological services. Together with its strong team, the VelaLabs Management aims to successfully realize its vision of the future and expand its base of operations.

Among the new goals are digitalization and expansion of its analytical method portfolio for innovative products, as well as GLP certification and ISO 17025 accreditation.

Philosophy

Our philosophy is to support our customers during the journey through the adventure of health.

With our help you have a competent partner in your side for the whole process of drug development that supports you with analytical development, clinical expertise and regulatory consulting.

VelaLabs stands for individual customer support, highest quality standards and professional expertise and we are an international partner for the pharma and biotechnology industry developing biopharmaceuticals and biosimilars.

Our solutions are not out-of-the-box and our flexible and dynamic team can provide tailored solutions for our customers while also having regulatory expertise.

GMP Certification

VelaLabs offers analytical test methods for medicinal drugs in the preclinical and clinical development phase. The analytical portfolio is based on International Conference for Harmonization (ICH) guidelines and covers non-cellular and cellular methods. The portfolio is further completed by advisory support for submission-relevant clinical studies and drug product release.

The most important tool for assuring the quality standards of VelaLabs is the GMP certification, which represents the highest level of quality in the pharmaceutical industry. Furthermore, VelaLabs is working compliant with GCLP guidelines for all bioanalytical services.

Our Analytical Lab Services

Memberships and Cooperation

VelaLabs collaborates with the St. Anna Children’s Hospital, which provides comprehensive care for the children and young people entrusted to them: The concept of the hospital integrates the treatment of patients according to the latest state of medical knowledge, care as support for self-care in close cooperation with caregivers and the psychosocial care of the patients and their families.

VelaLabs is member of Life Science Austria Vienna Region (LISA VR), which provides support and advice to start-ups and high-technology companies.

Vela is partner of the network and cluster of Human Technology Styria.

Biomedica is a leading distributor of medical devices, in-vitro diagnostics and products for Life Sciences. VelaLabs and Biomedica collaborate regarding the implementation, use, marketing and testing services of the GlycoTechnica LecChip technology.

Evercyte offers immortalized cells that retain their primary-like human cell characteristics. VelaLabs and Evercyte have a cooperation for the usage of immortalized cell lines for biosimilar characterization.

Long-term partners of VelaLabs are the Department of Clinical Pharmacology and the Coordination Center for Clinical Studies (KKS) both from the Medical University of Vienna.

BLS – Analytik GmbH & co. KG is a Tentamus laboratory, focusing on the physical, physical-chemical and chemical testing and analysis of pharmaceuticals, food, feed and cosmetic products. BLS is a fully GMP, FDA, and ISO 17025 inspected and approved laboratory.

BAV Institute is an accredited contract laboratory offering hygiene and quality control services in the fields of food, cosmetics, and pharma. In addition to microbial testing, the company specializes in on-site consulting and training.

Protagen Protein Services (PPS) is a leading CRO in protein analytics and its application to GMP-compliant characterization of protein therapeutics. PPS supports multiple biosimilar developers in achieving and demonstrating biosimilarity. Many years of experience of PPS in business and a comprehensive spectrum of validated analytical methods ensure highest quality for customers in the pharmaceutical, biotechnology and life science industry.

MPL Mikrobiologisches Prüflabor GmbH is the GMP certified partner of VelaLabs for microbiological analytics.

Customers

VelaLabs’s customers include some of the biggest names in Pharma and Biotech. Our focused, customer – orientated approach, a highly motivated team and a broad expertise in analytical development and quality control led to a trusting relationship that has met the requirements of our customers for over 10 years.

Pharma

Biotech

Read all news

Dicamba volatility tests via Humidome set-up at Symbiotic Research

International Trade Center, Mount Olive, New Jersey – SYMBIOTIC RESEARCH, LLC (SRL), announces the expansion of its agrochemical research services into conducting humidome studies with Dicamba formulations. US-EPA has requested companies marketing Dicamba formulations to use humidome set-ups to evaluate the effects of defined parameters on secondary movement of Dicamba. In controlled experimental settings provided ... Continued

ELISA vs. Biacore - A VelaLabs "Let's Talk About" for Download

June 2020: VelaLabs offers you a free download for a method comparison of pros and cons from ELISA versus surface plasmon resonance (SPR) methods with Biacore. ELISA and Biacore assays are based on the same analytical principles and have an orthogonal view on binding interactions. Conversion may only require the transfer of antibodies and buffer conditions ... Continued

Medical Device Regulation delayed to 2021

The replacement of the Medical Device Directive (MDD) with the Medical Device Regulation (MDR) has been delayed to 26 May, 2021. This delay is due to the COVID-19 pandemic, with the EU wanting medical device manufacturers to prioritize the production of medical devices which will help fight coronavirus. Implementing MDR regulations would require medical device ... Continued

Ketchup testing ahead of barbecue season

With barbecue season approaching, people will start craving a side of ketchup to partner their meat. Ketchup may however contain a variety of substances which come with legal limits. These substances include pesticides, mould toxins, and ergosterol. Along with the aforementioned substances, ketchup also includes lycopene. High amounts of lycopene in ketchup is considered a ... Continued

Renolab is extending its certification

In vitro pharmacodynamics (PD) for human use drugs with anti-infectious activity Starting from 2019, the microbiology department at Renolab is extending its certification, thus continuing the providing of pharmacodynamics (PD) services based on the relationship between the properties of new drugs and bactericidal, fungicidal and virucidal effects. The tests will be conducted following the ... Continued

All Shiga Toxine-producing Escherichia coli (STEC) subtypes are pathogenic

The Pathogenicity assessment of “Shiga toxine-producing Escherichia coli (STEC) and the public health risk posed by contamination of food with STEC” from 2013 was recently reviewed by EFSA. Based on the assessment it was concluded that all STEC strains are pathogenic in humans, capable of causing at least diarrhoea and that all STEC subtypes may ... Continued

We are at your service!